Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.
Activation of interferon regulatory factors (IRFs) 3 and 7 is essential for the induction of Type I interferons (IFN) and innate antiviral responses, and herpesviruses have evolved mechanisms to evade such responses. We previously reported that Epstein-Barr virus BZLF1, an immediate-early (IE) protein, inhibits the function of IRF7, but the role of BRLF1, the other IE transactivator, in IRF regulation has not been examined. We now show that BRLF1 expression decreased induction of IFN-beta, and reduced expression of IRF3 and IRF7; effects were dependent on N- and C-terminal regions of BRLF1 and its nuclear localization signal. Endogenous IRF3 and IRF7 RNA and protein levels were also decreased during cytolytic EBV infection. Finally, production of IFN-beta was decreased during lytic EBV infection and was associated with increased susceptibility to superinfection with Sendai virus. These data suggest a new role for BRLF1 with the ability to evade host innate immune responses.
Bentz
Gretchen L
GL
Lineberger Comprehensive Cancer Center, The University of North Carolina, Chapel Hill, NC, USA.
Liu
Renshui
R
Hahn
Angela M
AM
Shackelford
Julia
J
Pagano
Joseph S
JS
D030161:Avian Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology; D002460:Cell Line; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000472:pathogenicity*; D054884:Host-Pathogen Interactions; D006801:Humans; D017874:Immediate-Early Proteins / Q000502:physiology*; D050839:Interferon Regulatory Factor-7 / Q000037:antagonists & inhibitors* / Q000276:immunology; D050835:Interferon Regulatory Factors / Q000037:antagonists & inhibitors* / Q000276:immunology; D016899:Interferon-beta / Q000037:antagonists & inhibitors* / Q000276:immunology; D019913:Nuclear Localization Signals; D025941:Protein Interaction Mapping; D029082:Sendai virus / Q000254:growth & development; D015534:Trans-Activators / Q000502:physiology*; D014158:Transcription, Genetic
D030161:Avian Proteins; C068382:BRLF1 protein, Human herpesvirus 4; C094532:IRF-3 protein, Gallus gallus; C494234:IRF7 protein, human; D017874:Immediate-Early Proteins; D050839:Interferon Regulatory Factor-7; D050835:Interferon Regulatory Factors; D019913:Nuclear Localization Signals; D015534:Trans-Activators; D016899:Interferon-beta
Nat Rev Immunol. 2006 Sep;6(9):644-58
16932750
J Virol. 1998 Oct;72(10):7978-84
9733836
Virus Res. 2009 Mar;140(1-2):40-8
19084562
J Infect Dis. 2009 Jan 1;199(1):20-30
19012493
J Virol. 2004 Aug;78(16):8411-20
15280450
Eur J Biochem. 2004 Sep;271(18):3693-703
15355347
Biochimie. 2007 Jun-Jul;89(6-7):744-53
17399883
Virology. 2002 Feb 15;293(2):295-304
11886249
J Virol. 2004 Oct;78(20):10995-1006
15452220
J Virol. 2009 Jan;83(2):1140-6
18987133
Biochem Biophys Res Commun. 2003 Jul 11;306(4):860-6
12821121
Curr Top Microbiol Immunol. 2007;316:233-50
17969451
Nucleic Acids Res. 1991 May 25;19(10):2661-7
1645863
J Virol. 2004 Feb;78(4):1675-84
14747533
Science. 2003 May 16;300(5622):1145-8
12702807
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7840-3
1502204
Cytokine Growth Factor Rev. 1997 Dec;8(4):293-312
9620643
J Immunol. 1998 Aug 15;161(4):1947-53
9712065
Physiology (Bethesda). 2004 Aug;19:216-24
15304636
J Interferon Cytokine Res. 2004 Aug;24(8):439-54
15320958
J Virol. 2007 Apr;81(7):3077-86
17215277
Mol Cell Biol. 1997 Oct;17(10):5748-57
9315633
Nature. 2005 Mar 10;434(7030):243-9
15665823
J Biol Chem. 2005 Apr 1;280(13):12262-70
15664995
J Virol. 2003 Jul;77(14):7945-56
12829834
Mol Immunol. 2009 Aug;46(13):2640-6
19501403
J Virol. 2005 Sep;79(18):11671-6
16140744
J Biol Chem. 2004 Sep 10;279(37):38803-12
15229220
J Virol. 2008 Mar;82(6):2699-704
18199658
J Virol. 1989 Jan;63(1):445-9
2462063
J Biol Chem. 2000 Mar 31;275(13):9377-84
10734081
J Virol. 1989 Sep;63(9):3878-83
2548003
Mol Cell Biol. 2000 Sep;20(17):6342-53
10938111
J Virol. 2001 Jul;75(13):6135-42
11390615
J Virol. 2007 Jun;81(11):5737-48
17376932
J Virol. 2003 Sep;77(17):9359-68
12915551
Curr Top Microbiol Immunol. 2002;269:187-201
12224509
Curr Opin Infect Dis. 2004 Jun;17(3):199-203
15166821
J Virol. 2000 Feb;74(3):1224-33
10627532
J Virol. 1999 Sep;73(9):7271-7
10438815
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4776-80
8197134
J Virol. 2009 Jul;83(13):6757-68
19369349
J Virol. 2004 Apr;78(8):4197-206
15047835
J Interferon Cytokine Res. 2002 Jan;22(1):59-71
11846976
J Virol. 2002 Mar;76(5):2180-91
11836395
Immunity. 2006 Sep;25(3):349-60
16979567
Biochem Soc Trans. 2007 Dec;35(Pt 6):1512-4
18031256
J Virol. 2009 Feb;83(4):1856-69
19052084
Curr Top Microbiol Immunol. 2002;269:153-70
12224507
Annu Rev Immunol. 2008;26:535-84
18303999
Antimicrob Agents Chemother. 2004 May;48(5):1900-3
15105156
J Biol Chem. 2004 Oct 22;279(43):45194-207
15308637
J Gen Virol. 2005 Feb;86(Pt 2):317-322
15659750
Science. 2000 May 5;288(5467):874-7
10797013
Immunity. 2005 Jan;22(1):59-70
15664159
Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007
8393562
Nature. 2005 Apr 7;434(7034):772-7
15800576
J Virol. 1999 Dec;73(12):9858-66
10559298
J Interferon Cytokine Res. 2002 Jan;22(1):95-101
11846980
Virology. 2007 Apr 10;360(2):305-21
17126870
J Virol. 2009 Apr;83(8):3977-81
19176627
J Virol. 2009 Feb;83(3):1299-311
19036819
Cell. 1995 Dec 29;83(7):1091-100
8548797
Gene Expr. 1993;3(1):49-59
8389627
J Virol. 2005 Aug;79(15):10040-52
16014964
Curr Opin Infect Dis. 2002 Jun;15(3):259-67
12015460
Curr Top Microbiol Immunol. 2007;316:167-92
17969448
Biochim Biophys Acta. 1999 Jul 7;1446(1-2):140-4
10395927